ArticleOncotarget2016

The VEGF rise in blood of bevacizumab patients is not based on tumor escape but a host-blockade of VEGF clearance.

Lejla Alidzanovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.